Literature DB >> 1190294

Acute hyperuricemic nephropathy in rats. An electron microscopic study.

J Waisman, L M Mwasi, R Bluestone, J R Klinenberg.   

Abstract

Hyperuricemia and uricosuria were induced in rats fed uric acid and oxonic acid. Kidneys then were studied by light and electron microscopy. After 1 day of hyperuricemia, animals had deposits of uric acid and urate crystals within collecting tubules of the renal papillae, and tubular cells were altered. By 10 days, there was an exudative response with further injury to epithelium. Clear spaces within lumens, epithelium, and neutrophils suggested the presence of crystals; however, there was no direct ultrastructural evidence that neutrophils or epithelial cells ingested crystals and suffered injury. Presumably, crystals readily seen in frozen, unfixed tissue were lost during preparation for electron microscopy. Nonetheless, the ultrastructural findings indicated that hyperuricemic nephropathy was initiated in a fashion analogous to urate arthropathy. Urate crystals formed within collecting tubules, epithelial cells were altered, and most likely there was chemotaxis of neutrophils which underwent degranulation and vacuolation followed by lysis freeing any ingested urate. Release of ingested crystals plus precipitation of new crystals both might serve to sustain the nephritis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1190294      PMCID: PMC2032218     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  10 in total

1.  THE COMPETITIVE INHIBITION OF URICASE BY OXONATE AND BY RELATED DERIVATIVES OF S-TRIAZINES.

Authors:  I FRIDOVICH
Journal:  J Biol Chem       Date:  1965-06       Impact factor: 5.157

2.  Urate crystal induced inflammation in dog joints: sequence of synovial changes.

Authors:  H R Schumacher; P Phelps; C A Agudelo
Journal:  J Rheumatol       Date:  1974-03       Impact factor: 4.666

3.  A preliminary report of nephropathy in hyperuricemic rats.

Authors:  J Waisman; R Bluestone; J R Klinenberg
Journal:  Lab Invest       Date:  1974-06       Impact factor: 5.662

4.  Impaired renal clearance of uric acid in chickens having hyperuricemia and articular gout.

Authors:  R E Austic; R K Cole
Journal:  Am J Physiol       Date:  1972-09

5.  Ultrastructural study of leucocytes and urates in gouty arthritis.

Authors:  J M Riddle; G B Bluhm; M I Barnhart
Journal:  Ann Rheum Dis       Date:  1967-09       Impact factor: 19.103

6.  Uric acid nephropathy: an experimental model.

Authors:  B Stavric; W J Johnson; H C Grice
Journal:  Proc Soc Exp Biol Med       Date:  1969-02

7.  Biochemical considerations of the renal damage of gout.

Authors:  J E Seegmiller; P D Frazier
Journal:  Ann Rheum Dis       Date:  1966-11       Impact factor: 19.103

8.  Observations on phagocytosis of urate crystals by polymorphonuclear leucocytes.

Authors:  K T Rajan
Journal:  Ann Rheum Dis       Date:  1975-02       Impact factor: 19.103

9.  Ultrastructural evidence for leakage of lysosomal contents after phagocytosis of monosodium urate crystals. A mechanism of gouty inflammation.

Authors:  T Shirahama; A S Cohen
Journal:  Am J Pathol       Date:  1974-09       Impact factor: 4.307

10.  Mechanisms of lysosomal enzyme release from leukocytes. IV. Interaction of monosodium urate crystals with dogfish and human leukocytes.

Authors:  S Hoffstein; G Weissmann
Journal:  Arthritis Rheum       Date:  1975 Mar-Apr
  10 in total
  3 in total

Review 1.  Autophagy and kidney inflammation.

Authors:  Tomonori Kimura; Yoshitaka Isaka; Tamotsu Yoshimori
Journal:  Autophagy       Date:  2017-04-25       Impact factor: 16.016

Review 2.  Uric acid as a target of therapy in CKD.

Authors:  Diana I Jalal; Michel Chonchol; Wei Chen; Giovanni Targher
Journal:  Am J Kidney Dis       Date:  2012-10-09       Impact factor: 8.860

3.  A micropuncture study of the early phase of acute urate nephropathy.

Authors:  J D Conger; S A Falk; S J Guggenheim; T J Burke
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.